GenHealth.ai
Use Cases
Products
Company
Research
Get a Demo
See how we Automate Prior Authorization
Use our Population Health Analytics Co-pilot
Search all medical codes
T45.515A
Adverse effect of anticoagulants, initial encounter
ICD10CM code
Medical Policies and Guidelines for Adverse effect of anticoagulants, initial encounter
Related policies from health plans
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
T45.515A
- Adverse effect of anticoagulants, initial encounter
T45.515D
- Adverse effect of anticoagulants, subsequent encounter
T45.525A
- Adverse effect of antithrombotic drugs, initial encounter
T45.7X5A
- Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.625A
- Adverse effect of hemostatic drug, initial encounter
T45.525D
- Adverse effect of antithrombotic drugs, subsequent encounter
T45.515
- Adverse effect of anticoagulants
T45.7X5D
- Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
T45.515S
- Adverse effect of anticoagulants, sequela
T45.615A
- Adverse effect of thrombolytic drugs, initial encounter
HCPCS codes
G8696
- Antithrombotic therapy prescribed at discharge
G8969
- Documentation of patient reason(s) for not prescribing warfarin or another fda-approved oral anticoa
G9724
- Patients who had documentation of use of anticoagulant medications overlapping the measurement year
G8967
- Warfarin or another fda approved oral anticoagulant is prescribed
G8968
- Documentation of medical reason(s) for not prescribing warfarin or another fda-approved anticoagulan
G9928
- Warfarin or another fda-approved anticoagulant not prescribed, reason not given
G8971
- Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
S9401
- Anticoagulation clinic, inclusive of all services except laboratory tests, per session
G8972
- One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboe
G9298
- Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days
CPT4 codes
85301
- Clotting inhibitors or anticoagulants; antithrombin III, antigen assay
99364
- Anticoagulant management for an outpatient taking warfarin, physician review and interpretation of I
85305
- Clotting inhibitors or anticoagulants; protein S, total
99363
- Anticoagulant management for an outpatient taking warfarin, physician review and interpretation of I
93793
- Anticoagulant management for a patient taking warfarin, must include review and interpretation of a
85300
- Clotting inhibitors or anticoagulants; antithrombin III, activity
85525
- Heparin neutralization
3555F
- Patient had International Normalized Ratio (INR) measurement performed (AFIB)
85302
- Clotting inhibitors or anticoagulants; protein C, antigen
36593
- Declotting by thrombolytic agent of implanted vascular access device or catheter
Choose how you'd like to learn more
Email
Send us a message or questions and we can share more details.
Name
Email
Message
Company Name
Submit
Meet
Setup a calendar meeting with us; find a time now.
DIY Demo
Sign up for a free account to see our product in action.
Demo Gen AI Healthcare Analytics